Advagene Biopharma Co., Ltd. (TPEX:6709)

Advagene Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,565	1,220	1,355	1,479	2,396	1,467
Market Cap Growth	30.45%	-9.95%	-8.37%	-38.27%	63.30%	65.89%
Enterprise Value	1,401	1,130	1,294	1,322	2,125	1,259
Last Close Price	26.35	20.55	25.40	29.73	48.31	32.75
PB Ratio	8.35	5.53	9.68	11.22	9.60	4.90
P/TBV Ratio	8.35	5.53	9.68	12.13	9.96	5.14
Debt / Equity Ratio	0.02	0.03	-	0.02	0.02	0.02
Quick Ratio	30.73	31.56	18.25	14.51	29.07	23.32
Current Ratio	30.83	31.63	18.37	14.94	29.50	23.47
Return on Equity (ROE)	-48.04%	-38.51%	-67.80%	-62.09%	-33.77%	-24.59%
Return on Assets (ROA)	-28.28%	-23.29%	-40.40%	-37.32%	-20.47%	-15.91%
Return on Invested Capital (ROIC)	-29.93%	-24.17%	-42.62%	-38.68%	-21.14%	-16.44%
Return on Capital Employed (ROCE)	-38.30%	-31.50%	-66.70%	-90.50%	-37.50%	-25.00%
Earnings Yield	-4.54%	-5.69%	-6.80%	-8.00%	-3.87%	-4.78%
FCF Yield	-4.92%	-5.83%	-5.73%	-7.41%	-2.83%	-2.15%
Buyback Yield / Dilution	-10.02%	-8.47%	-2.14%	-1.23%	-9.95%	-0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.